Cell and Gene Therapy Investor Panel and Happy Hour

​Join us during the BIO Investor Forum in San Francisco to hear about startup investment trends in cell therapy. RSVP required. 

​The Ajinomoto Corporate Venture Capital Team, in collaboration with IndieBio, is hosting an invite-only Biotech Investor Networking event at the new Indie Bio/SOSV space. You’ll meet leading cell therapy investors, startups, and stakeholders. 

​A short panel discussion on the cell therapy and investor landscape will be hosted by Max von Poelnitz, Managing Director of Ajinomoto Venture Capital.   

​​Panelists include: 

​​David Yang, Life Science Investor - Lux Capital 

​​Westley Dang, Chief Science Officer - IndieBio  

​You’ll learn about:  

​Gene and cell therapy funding has seen a sharp drop-off this year. What does it say about future developments in the sector ? 

​Where do we see major innovation coming in the next 3 years? 

​​What are the challenges driving the adoption of allogeneic cell therapy? 

​Event details:  

​Oct 16, 4:30 PM – 6:30 PM

​IndieBio 2565 3rd St Suite 318, San Francisco 

​​Snacks and Cocktails will be served, including a special ​MSG Martini and Ajinomoto Yuzu Mojito 

​Space is limited. RSVP required.